Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_assertion type Assertion NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_head.
- NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_assertion description "[Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_provenance.
- NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_assertion evidence source_evidence_literature NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_provenance.
- NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_assertion SIO_000772 18448549 NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_provenance.
- NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_assertion wasDerivedFrom befree-2016 NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_provenance.
- NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_assertion wasGeneratedBy ECO_0000203 NP668688.RAQ_KaGcQ-Xnmzu5R166G6RXuKq3WbebNGTc7_vFV-VVc130_provenance.